The seemingly opposite outcomes from decreased insulin receptor and IGF-1 receptor signaling implies that either they initiate different pathways or they share the same signaling pathway but bi-directionally regulate Aβ toxicity and synaptic loss in Alzheimer's disease. The gene discussed is INSR; the disease is early-onset autosomal dominant Alzheimer disease.